TEVA PHARMACEUT. SP.ADR revenue breakdown overview

TEVA PHARMACEUT. SP.ADR revenue for the last year amounted to 14.36 B EUR, the most of which — 14.36 B EUR — came from its highest performing source at the moment, Generics, Innovative Medicines and Over-the-counter Products, the year earlier bringing 13.95 B EUR. The greatest contribution to the revenue figure was made by North America — last year it brought TEVA PHARMACEUT. SP.ADR 7.36 B EUR, and the year before that — 6.96 B EUR.